Yes, injection site reactions are expected with lipotropic injections
PlushCare physicians perform initial screening but typically do not order metabolic labs or assess genetic factors in GLP-1 response
Tirzepatide has shown to have anti-inflammatory, metabolic, and cardiovascular effects that could be promising to long Covid patients. One published study found that in 47 people with mast cell activation syndrome, or MCAS, a condition in which white blood cells release inflammatory chemicals, 89 percent benefited from a GLP-1, especially at low doses
To support patients day after day - from treatment initiation through long-term management
Additionally, the absence of laboratory values (e.g., HbA1c, TSH) limits adjustment for disease severity and assessment of over-replacement
Kelly's Journey: Conquering Weight Loss and Embracing Life at 49 with Tirzepatide My name is Kelly